Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 19, 2023 - Issue 1
Submit an article Journal homepage
836
Views
2
CrossRef citations to date
0
Altmetric
Coronavirus

Heterologous mRNA-based COVID-19 booster strategies: Comment

Sora Yasria KM Center, Bangkok, ThailandCorrespondence[email protected]
View further author information
&
Viroj Wiwanitkitb Department of Biological Science, Joseph Ayo Babalola University, Ikeji-Arakeji, NigeriaView further author information
Article: 2174758 | Published online: 16 Feb 2023

References

  • Das R, Hyer RN, Burton P, Miller JM, Kuter BJ Emerging heterologous mRNA-based booster strategies within the COVID-19 vaccine landscape. Hum Vaccin Immunother. 2023 Jan 11:2153532. doi: 10.1080/21645515.2022.2153532. Online ahead of print.
  • Joob B, Wiwanitkit V. Letter to the Editor: coronavirus disease 2019 (COVID-19), infectivity, and the incubation period. J Prev Med Public Health. 2020 Mar;53(2):70. doi:10.3961/jpmph.20.065.
  • Čiučiulkaitė I, Möhlendick B, Thümmler L, Fisenkci N, Elsner C, Dittmer U, Siffert W, Lindemann M. GNB3 c.825c>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine. Front Genet. 2022 Aug 29;13:932043. doi:10.3389/fgene.2022.932043.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.